Eleven biotherapeutics stock price
Historical daily share price chart and data for SESEN BIO, INC since 2020 adjusted for splits. The latest closing stock price for SESEN BIO, INC as of April 03, 2020 is 0.52.. The all-time high SESEN BIO, INC stock closing price was 3.29 on May 03, 2018.; The SESEN BIO, INC 52-week high stock price is 2.60, which is 400% above the current share price. 5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics ... Eleven Biotherapeutics Last on our weekly 5 top NASDAQ biotech stocks list is a company that hasn’t been on the list in close to two years–Eleven Biotherapeutics. For Eleven Biotherapeutics (NASDAQ:EBIO), Cancer Trial ... Mar 20, 2018 · Eleven Biotherapeutics, Inc. (NASDAQ: EBIO), a Cambridge, Massachusetts-based developer of targeted protein therapeutics, has been showing promising clinical data for TPT-based Price Target Analysis: Eleven Biotherapeutics, Inc ... Feb 07, 2017 · When it comes to the Analysis of a Stock, Price Target plays a vital role. 1 Analysts reported that the Price Target for Eleven Biotherapeutics, …
Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk,
Jul 29, 2016 · The average volume for Eleven Biotherapeutics has been 3.6 million shares per day over the past 30 days. Eleven has a market cap of $69.2 million and is part of the health care sector and drugs Eleven Biotherapeutics: An Assessment Of A Potential Big ... Apr 23, 2018 · Targeted protein therapeutics is a novel and sound approach to the localized cancer destruction. Phase 3 (VISTA) trial, studying Actinium in patients … EBIO — Stock Price and Discussion | Stocktwits Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, Eleven Biotherapeutics: What The Q1 2018 Earnings Foretell ... May 15, 2018 · Eleven Biotherapeutics (NASDAQ:EBIO) is an intriguing company that is volatile. In the past 52-week, the stock traded up by $1.11 at $2.65 for over 65% profits. In the past 3 …
View SESEN BIO, INC. SESN investment & stock information. Get the latest SESEN BIO, INC. SESN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
May 15, 2018 · Eleven Biotherapeutics (NASDAQ:EBIO) is an intriguing company that is volatile. In the past 52-week, the stock traded up by $1.11 at $2.65 for over 65% profits. In the past 3 … NASDAQ:EBIO Eleven Biotherapeutics, Inc. Stock Analysis ... Eleven Biotherapeutics, Inc. is a biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it apply to the discovery and development of protein therapeutics to treat diseases of the eye. Eleven Biotherapeutics Prices Initial Public Offering ... Feb 06, 2014 · In addition, Eleven has granted the underwriters an option for a period of 30 days to purchase, at the public offering price less the underwriting discount, up to 750,000 additional shares of Sesen Bio awareness. There is an outstanding need for new treatments for bladder cancer. We are proud to support the Bladder Cancer Advocacy Network in building awareness of the need for a cure.
In depth view into SESN (Sesen Bio) stock including the latest price, news, 05/ 13/2019, Earnings, Eleven Biotherapeutics Inc First Quarter Earnings in 2019
AGLE Price Target | Aeglea Biotherapeutics Stock Forecast ...
Eleven Biotherapeutics (EBIO) in Focus: Stock Moves 8.7% ...
Real time Iovance Biotherapeutics, Inc. (IOVA) stock price quote, stock graph, news & analysis.
Stock analysis for Sesen Bio Inc (EBIO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.